Skip to main content
SpringerLink
Log in

Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies

  • Original Articles
  • Poor risk malignancies, High-Dose Chemotherapy, Bone Marrow Transplantation, Toxicity, Lymphomas
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Twenty-six patients (median age 33 years) with poor-risk malignancies were treated with high-dose combination chemotherapy associating BCNU-etoposide-cytosine arabinoside and melphalan (BEAM) followed by autologous bone marrow transplantation (ABMT). Twenty-one patients had malignant lymphomas, three, acute lymphoblastic leukemia (ALL), and two, malignant thymomas. Eleven patients (group 1) were not in complete remission (CR) at the time of BEAM, and fifteen patients (group 2) were in CR. Hematological recovery occurred in all patients. The duration of aplasia and the non-hematological toxicities were similar in both groups. Ten of the eleven patients (group 1) evaluable for response achieved CR and one achieved partial remission (PR). Five patients relapsed, and five are in continuous CR with a short follow-up (median 8 months). Among the fifteen patients in CR at the time of BEAM (group 2), four patients relapsed and ten patients are in unmaintained continuous CR with a median follow-up of 15 months (one patient died in CR). The disease-free survival is 53%, with 29% for patients receiving BEAM while in relapse (group 1) and 65% for patients receiving BEAM while in CR (group 2). These data indicate that BEAM followed by ABMT can produce a high antitumor response with an acceptable toxicity in patients with poor-risk malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anderson CC, Goldstone AH, Souhami RL, Linch DC, Harper PG, McLennan KA, Jones M, Machin SJ, Jelliffe AM, Cawley JC, Richards JDM (1986) Very-high-dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphoma. Cancer Chemother Pharmacol 16: 170–175

    Google Scholar 

  2. Appelbaum FR, Thomas ED (1983) Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma. J Clin Oncol 1: 440–447

    Google Scholar 

  3. Appelbaum FR, Deisseroth AB, Graw RG, Herzig GP, Levine AS, Magrath IT, Pizzo PA, Poplack DG, Ziegler JL (1978) Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse. Cancer 41: 1059–1063

    Google Scholar 

  4. Bonadonna G (1982) Chemotherapy strategies to improve the control of Hodgkin's disease. Cancer Res 42: 4309–4320

    Google Scholar 

  5. Cabanillas F, Hagemeister F, Bodey GP, Freireich EJ (1982) IMVP16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood 60: 693–697

    Google Scholar 

  6. Carella AM, Santini G, Giordano D, Frassoni F, Nati S, Congiu A, Occhini D, Rossi E, Martinengo M, Damasio E, Lercari G, Marmont AM (1984) High dose chemotherapy and non-frozen autologous bone marrow transplantation in relapsed advanced lymphomas or those resistant to conventional chemotherapy. Cancer 54: 2836–2839

    Google Scholar 

  7. Carter SK, Wasserman TH (1976) The nitrosoureas: thoughts for the future. Cancer Treat Rep 60: 807–811

    Google Scholar 

  8. Coiffier B, Bryon PA, Berger F, Archimbaud E, French M, Extra JM, Guyotat D, Fiere D, Gentilhomme O, Magaud JP, Blanc M, Peaud PY, Vuvan H, Viala JJ (1986) Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (Protocol LNH 80). J Clin Oncol 4: 147–153

    Google Scholar 

  9. Cornbleet MA, Corringham RET, prentice HG, Boesen EM, McElwain TJ (1981) Treatment of Ewing's sarcoma with high dose melphalan. Cancer Treat Rep 65: 241–244

    Google Scholar 

  10. Dicke KA, Spitzer G (1986) Evaluation of the use of high dose cytoreduction with autologous marrow rescue in various malignancies. Transplantation 41: 4–20

    Google Scholar 

  11. Ernst P, Maraninchi D, Jacobsen N, Kolb HJ, Bordigoni P, Ljungman P, Bandini G, Parker AC, Volin L, Powles R, Gorin NC, Rio B (1986) Marrow transplantation for non-Hodgkin's lymphoma: a multicentre study from the European Cooperative Bone Marrow Transplant Group. Bone Marrow Transplant 1: 81–86

    Google Scholar 

  12. Extra JM, Fiere D, Marty M, David B, Witz F, Sotto JJ, Gastaut JA for French Group for Treatment of Adult ALL (1985) Treatment of 225 adults with acute lymphoblastic leukemia (ALL). Initial results (1985). 27th meeting of ASH, New Orleans

  13. Goldstone AH (1985) Autologous bone marrow transplantation for non Hodgkin's lymphoma: the preliminary european experience. In: Dicke KA, Spitzer G, Zander AR (eds) Autologous bone marrow transplantation: proceedings of the first international symposium. University of Texas, M. D. Anderson Hospital and Tumor Institute. Houston, pp 67–74

    Google Scholar 

  14. Gorin NC, David R, Stachowiak J, Salmon C, Petit JC, Darlier Y, Najman A, Duhamel G (1981) High-dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. Eur J Cancer 17: 557–568

    Google Scholar 

  15. Hartmann O, Pein F, Beaujean F, Kalifa C, Datte C, Parmentier C, Lemerle J (1984) High-dose polychemotherapy with autologous bone marrow transplantation in children with relapsed lymphomas. J Clin Oncol 2: 979–993

    Google Scholar 

  16. Hartmann O, Benhamou E, Beaujean F, Pico JL, Kalifa C, Patte C, Flamant F, Lemerle J (1986) High-dose Busulfan and Cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study. J Clin Oncol 4: 1804–1810

    Google Scholar 

  17. Hervé P, Coffé C, Tamayo E, Lentz R, Peters A (1977) Collection and cryopreservation of bone marrow and clinical applications. In: Therapy of acute leukemia. Proceedings of the Second International Symposium, Rome. p 592

  18. Herve P, Racadot E, Tamayo E, Maraninchi D, Tubiana N, Carcassonne Y, Boucheix C, Marie JP, Choquet C, Pillier C, Zittoun R (1983) In vitro treatment with anti-calla monoclonal antibody (mo Ab) with a view to autologous stem cell transplantation. Comparative studies of 3 monoclonal anti-calla and first clinical study. In: Lowenberg B, Hagenbeck A (eds) Minimal residual disease of acute leukemia. Proceedings of an international symposium. Nijhoff, Rotterdam

    Google Scholar 

  19. Kantarjian H, Barlogie B, Plunkett W, Velasquez W, McLaughlin P, Riggs S, Cabanillas F (1983) High-dose cytosine arabinoside in non-Hodgkin's lymphoma. J Clin Oncol 1: 689–694

    Google Scholar 

  20. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481

    Google Scholar 

  21. Klimo P, Connors JM (1985) MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma. Ann Intern Med 102: 596–602

    Google Scholar 

  22. Kremer WB (1975) Cytarabine. Ann Intern Med 82: 684–688

    Google Scholar 

  23. Lazarus HM, Herzig RH, Graham Pole J, Wolff SN, Phillips GL, Strandjord S, Hurd D, Forman W, Gordon EM, Coccia P, Cross S, Herzig GP (1983) Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer. J Clin Oncol 1: 359–367

    Google Scholar 

  24. Lumley HS, Powles R, Morgenstern G, Clink HM, McElwain TJ (1981) Pseudosyngeneic transplantation as a treatment for recurrent leukaemia following allogenic bone marrow transplantation. In: Tourraine IL, Gluckman E, Griscelli C (eds) Bone marrow transplantation in Europe, vol 2. Excerpta Medica, Amsterdam, p 24

    Google Scholar 

  25. Maraninchi D, Abecassis M, Gastaut JA, Sebahoun G, Cahn JY, Herve P, Novakovitch G, Carcassonne Y (1983) High dose melphalan and autologous bone marrow transplant for relapsed acute leukemia. Cancer Chemother Pharmacol 10: 109–111

    Google Scholar 

  26. Maraninchi D, Pico JL, Hartmann O, Gastaut JA, Kamioner D, Hayat M, Mascret B, Beaujean F, Sebahoun G, Novakovitch G, Lemerle J, Carcassonne Y (1985) High dose melphalan with or without marrow transplantation: a study of dose-effect in patients with refractory and/or relapsed acute leukemias. Cancer Treat Rep 70: 445–448

    Google Scholar 

  27. Maraninchi D, Novakovitch G, Laurent G, Mascret B, Tubiana N, Derocq JM, Casellas P, Gastaut Ja, Perrimond H, Carcassonne Y (1985) Bone marrow transplantation after in vitro purging with T 101 Ricin-A Immunotoxin: a phase I clinical study. In: Dicke KA, Spitzer G, Zander AR (eds) Autologous bone marrow transplantation: proceedings of the first international symposium. University of Texas, M. D. Anderson Hospital and tumor Institute, Houston

    Google Scholar 

  28. Mascret B, Maraninchi D, Gastaut JA, Baume D, Sebahoun G, Lejeune C, Novakovitch G, Sainty D, Horchowski N, Tubiana N, Carcassonne Y (1985) Phase I–II study of high dose melphalan and autologous marrow transplantation in adult patients with poor risk non-Hodgkin's lymphomas. Cancer Chemother Pharmacol 14: 216–221

    Google Scholar 

  29. McElwain TJ, Hedley DM, Burton G, Clink HM, Gordon MY, Jarman M, Juttner Ca, Millar JL, Milsted RA, Prentice HG, Smith IE, Spence D, Woods M (1979) Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan. Br J Cancer 40: 72–80

    Google Scholar 

  30. Patte C, Philip T, Bernard A (1984) Improvement of survival in advanced stages of B cell non-Hodgkin's lymphomas of childhood. Proc Am Soc Clin Oncol 973: 340

    Google Scholar 

  31. Philip T, Biron P, Hervé P, Dutoul L, Ehrsam A, Philip I, Souillet G, Plouvier E, Le Mevel A, Philippe N, Vuvan O, Bouffet E, Bachmann P, Cordier JF, Freycon F, Mentighy-Brunat M (1983) Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis. Eur J Cancer Clin Oncol 19: 1371–1379

    Google Scholar 

  32. Philip T, Biron P, Maraninchi D, Gastaut JA, Hervé P, Flesh Y, Goldstone AH, Souhami RL (1984) Role of massive chemotherapy and autologous bone marrow transplantation in non-Hodgkin's malignant lymphoma. Lancet I: 391

    Google Scholar 

  33. Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cahn JY, Colombat P, Goldstone AH, Gorin NC, Flesh M, Laporte JP, Maraninchi D, Pico JL, Bosly A, Anderson C, Shors R, Biron P, Cabanillas F, Dicke K (1987) High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non Hodgkin's lymphoma. N Engl J Med 316: 1493–1498

    Google Scholar 

  34. Phillips GL, Herzig RH, Lazarus HM, Fay JW, Wolff SN, Mill WB, Thomas PR, Glasgow GP, Herzig GP (1984) Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation and transplantation cryopreserved autologous marrow. N Engl J Med 310: 1557–1561

    Google Scholar 

  35. Rappaport H (1966) Tumor of hematopoietic system. Armed Forces Institute of Pathology, Washington, DC p 91

    Google Scholar 

  36. Rodriguez V, Cabanillas F, Burgess MA, McKelvey EM, Valdivieso M, Bodey GP, Freireich EJ (1977) Combination chemotherapy (CHOP-Bleo) in advanced (non-Hodgkins) malignant lymphoma. Blood 49: 325–333

    Google Scholar 

  37. Rosenberg SA (1977) Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphoma. Cancer Treat Rep 61: 1023–1028

    Google Scholar 

  38. Schaeffer NW, Novwzoustan MR, Ohl S, Schmidt CG (1978) Cryopreservation of bone marrow. In: Cell separation and cryobiology. Schattauer, Stuttgart, p 243

    Google Scholar 

  39. Singer Cr, Goldstone AH (1986) Clinical studies of ABMT in non-Hodgkin's lymphoma. Clin Haematol 15: 105–150

    Google Scholar 

  40. Skarin A, Canellos G, Rosenthal D, Case D, Mononey W, Frei E (1980) Therapy of diffuse histiocytic (DH) and undifferentiated (DV) lymphoma with high dose Methotrexate and Citrovorum factor rescue (MTX, CF), Bleomycin (B), Adriamycin (A), Cyclophosphamide (C), Oncovin (O), and Decadron (D) (M-BACOD). Proc Am Soc Clin Oncol 21: 463 (Abstr no. C-568).

    Google Scholar 

  41. Tannir NM, Spitzer G, Zander AR, Jagannath S, Kanojia M, Vellekoop L, McLaughlin P, Hagemeister FJ, Dicke KA (1983) High dose chemoradiotherapy and bone marrow transplantation in patients with refractory lymphoma. Eur J Cancer Clin Oncol 19: 1092–1096

    Google Scholar 

  42. Thomas ED, Buckner CD, Banaji M (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Blood 49: 511–533

    Google Scholar 

  43. Thomas ED, Buckner CD, Clift RA (1979) Marrow transplantation for acute non-lymphoblastic leukaemia in first remission. N Engl J Med 301: 597–599

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France

    M. H. Gaspard, D. Maraninchi, A. M. Stoppa, J. A. Gastaut, N. Tubiana, D. Blaise, D. Sainty, N. Horchowski & Y. Carcassonne

  2. Pediatric Unit, CHU Timone, Marseille, France

    G. Michel

  3. Blood Bank, CTS, Marseille, France

    G. Novakovitch

  4. Centre Hospitalier, Avignon, France

    J. F. Rossi

  5. CHU Timone, Marseille, France

    P. J. Weiller

Authors
  1. M. H. Gaspard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Maraninchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. M. Stoppa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. A. Gastaut
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Michel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Tubiana
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Blaise
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Novakovitch
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. F. Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. P. J. Weiller
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. D. Sainty
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. N. Horchowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Y. Carcassonne
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gaspard, M.H., Maraninchi, D., Stoppa, A.M. et al. Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies. Cancer Chemother. Pharmacol. 22, 256–262 (1988). https://doi.org/10.1007/BF00273421

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00273421

Keywords

Search

Navigation